We are live on
!
Find out more
TI
Turner Investments Portfolio holdings
AUM
$134K
1-Year Est. Return
49.03%
This Fund
S&P 500
This Quarter
Est. Return
+10.67%
1 Year Est. Return
-49.03%
3 Year Est. Return
+6.36%
5 Year Est. Return
+75.79%
10 Year Est. Return
–
AUM
$547M
AUM Growth
-$9.74M
(-1.8%)
Cap. Flow
-$42M
Cap. Flow
% of AUM
-7.68%
Top 10 Holdings %
Top 10 Hldgs %
16.06%
Holding
480
New
78
Increased
86
Reduced
74
Closed
239
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VF Corp
VFC
|
+$5.76M |
| 2 |
ACHN
Achillion Pharmaceuticals
ACHN
|
+$5.22M |
| 3 |
Cencora
COR
|
+$4.35M |
| 4 |
Netflix
NFLX
|
+$4.25M |
| 5 |
Starbucks
SBUX
|
+$3.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$5.47M |
| 2 |
Hershey
HSY
|
+$3.86M |
| 3 |
Ambarella
AMBA
|
+$3.62M |
| 4 |
Sprouts Farmers Market
SFM
|
+$3.42M |
| 5 |
PTC Therapeutics
PTCT
|
+$3.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.46% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 10.94% |
| 4 | Financials | 9.21% |
| 5 | Industrials | 5.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OCRX
226
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $380K | 0.07% |
100,078
+33,138
| +50% | +$127K |
|
227
Toll Brothers
TOL
$14.5B
| $373K | 0.07% |
+9,760
| New | +$365K |
|
228
iShares Europe ETF
IEV
$1.69B
| $337K | 0.06% |
+7,710
| New | +$355K |
|
|
SC
229
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $320K | 0.06% |
+12,500
| New | +$305K |
|
230
SuperCom
SPCB
$67.3M
| $317K | 0.06% |
+125
| New | +$295K |
|
231
Pool Corp
POOL
$7.51B
| $298K | 0.05% |
+4,240
| New | +$289K |
|
232
Wabtec
WAB
$50B
| $283K | 0.05% |
3,000
+150
| +5% | +$14.7K |
|
233
Align Technology
ALGN
$12.5B
| $282K | 0.05% |
+4,500
| New | +$266K |
|
|
SPLK
234
DELISTED
Splunk Inc
SPLK
| $278K | 0.05% |
+4,000
| New | +$269K |
|
235
Freshpet
FRPT
$3.51B
| $249K | 0.05% |
+13,380
| New | +$280K |
|
|
HBI
236
DELISTED
Hanesbrands
HBI
| $233K | 0.04% |
7,000
-8,700
| -55% | -$285K |
|
|
ACTA
237
DELISTED
Actua Corp
ACTA
| $214K | 0.04% |
15,000
-122,460
| -89% | -$1.7M |
|
|
TWOU
238
DELISTED
2U Inc
TWOU
| $209K | 0.04% |
216
-92
| -30% | -$76.4K |
|
239
Ulta Beauty
ULTA
$23.2B
| $201K | 0.04% |
1,300
+300
| +30% | +$46.1K |
|
|
SFE
240
DELISTED
Safeguard Scientifics, Inc.
SFE
| $195K | 0.04% |
+10,000
| New | +$184K |
|
|
ICD
241
DELISTED
Independence Contract Drilling, Inc.
ICD
| $102K | 0.02% |
577
-5,883
| -91% | -$921K |
|
242
Ameris Bancorp
ABCB
$5.97B
| – | – |
-9,310
| Closed | -$246K |
|
243
Adobe
ADBE
$103B
| – | – |
-17,180
| Closed | -$1.27M |
|
|
ADVM
244
DELISTED
Adverum Biotechnologies
ADVM
| – | – |
-2,982
| Closed | -$1.21M |
|
245
Agnico Eagle Mines
AEM
$83.8B
| – | – |
-17,380
| Closed | -$486K |
|
|
AGEN
246
Agenus
AGEN
$324M
| – | – |
-255
| Closed | -$26K |
|
|
ALE
247
DELISTED
Allete
ALE
| – | – |
-80
| Closed | -$4K |
|
248
Alaska Air
ALK
$5.81B
| – | – |
-90
| Closed | -$6K |
|
249
Amkor Technology
AMKR
$13.4B
| – | – |
-450
| Closed | -$4K |
|
|
AMRN
250
Amarin Corp
AMRN
$302M
| – | – |
-29,062
| Closed | -$1.36M |
|
Similar funds
IP
DVC
PAM
CCM
GA
IPLA
LRM
HC
Turner Investments's Q2 2015 Portfolio in Review
As of Q2 2015, Turner Investments held 480 positions worth $547M, down 1.8% from $556M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Turner Investments withdrew a net $42M in Q2 2015, closing 239 positions and reducing 74 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $5.47M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Turner Investments opened a new position in VF Corp worth $5.6M.
- Turner Investments's largest Q2 2015 buy was VF Corp: 85,226 shares worth $5.6M.
- Turner Investments added most to Cencora in Q2 2015, an estimated $4.35M increase.
- Turner Investments's biggest Q2 2015 reduction was Ambarella, cutting an estimated $3.62M.
- Turner Investments fully exited Alexion Pharmaceuticals in Q2 2015, selling an estimated $5.47M.
- Turner Investments's ten largest holdings make up 16% of its $547M portfolio in Q2 2015.
- Turner Investments opened 78 new positions and closed 239 in Q2 2015.
- Turner Investments's portfolio value fell 1.8% quarter-over-quarter to $547M.
Based on Turner Investments's 13F filing for Q2 2015, filed 12 Aug 2015.